Comparative efficacy of once daily parnaparin and unfractionated heparin in unstable angina pectoris: PRIME CARE study

Indian Heart Journal

Volumn 57, Issue 6, 2005, Pages 648-654

  Joshi, V V ^a  

^a USV Limited   (India)

Author keywords

Low molecular weight heparin; Unfractionated heparin; Unstable angina

Indexed keywords

ACETYLSALICYLIC ACID; ANTIANGINA PECTORIS AGENT; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PARNAPARIN;

ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DEATH; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; DYSLIPIDEMIA; ECCHYMOSIS; EPISTAXIS; FEMALE; FOLLOW UP; HEALTH CARE NEED; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEMATOMA; HEMATURIA; HUMAN; HYPERTENSION; INDIAN; INJECTION SITE BLEEDING; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SEX; STANDARD; STATISTICAL SIGNIFICANCE; THORAX PAIN; TRANSLUMINAL CORONARY ANGIOPLASTY; UNSTABLE ANGINA PECTORIS;

AGED; ANGINA, UNSTABLE; CHI-SQUARE DISTRIBUTION; CONFIDENCE INTERVALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART FUNCTION TESTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33644671315     PISSN: 00194832     EISSN: 00194832     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Bleifeld W, Hamm CW, Braunwald E. Unstable Angina, Springer Verlag, 1990, 270 pp
2. Collins P, Fox KM. Pathophysiology of angina. Lancet 1990; 335: 94-96
3. Kruskal JB, Commerford PJ, Franks JJ, Kirsch RE. Fibrin and fibrinogen-related antigens in patients with stable and unstable coronary artery disease. N Engl J Med 1987; 317: 1361-1365
4. Freeman MR, Williams AE, Chisholm RJ, Armstrong PW. Intracoronary thrombus and complex morphology in unstable angina. Relation to timing of angiography and in-hospital cardiac events. Circulation 1989; 80: 17-23
5. Zalewski A, Shi Y, Nardone D, Bravette B, Weinstock P, Fischman D. et al. Evidence for reduced fibrinolytic activity in unstable angina at rest. Clinical, biochemical, and angiographic correlates. Circulation 1991; 83: 1685-1691
6. Falk E. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. Circulation 1985; 71: 699-708
7. Brown KA, Okada RD, Boucher CA, Phillips HR, Strauss HW, Pohost GM. Serial thallium-201 imaging at rest in patients with unstable and stable angina pectoris: relationship of myocardial perfusion at rest to presenting clinical syndrome. Am Heart J 1983; 106: 70-77
8. Cairns JA, Singer J, Gent M, Holder DA, Rogers D, Sackett DL, et al. One year mortality outcomes of all coronary and intensive care unit patients with acute myocardial infarction, unstable angina or other chest pain in Hamilton, Ontario, a city of 375,000 people. Can J Cardiol 1989; 5: 239-246
9. Ambrose JA, Hjemdahl-Monsen C, Borrico S, Sherman W, Cohen M, Gorlin R, et al. Quantitative and qualitative effects of intracoronary streptokinase in unstable angina and non-Q wave infarction. J Am Coll Cardiol 1987; 9: 1156-1165
10. Davies MJ, Thomas AC. Plaque fissuring - the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J 1985; 53: 363-373
11. Theroux P, Waters D, Lam J, Juneau M, McCans J. Reactivation of unstable angina after the discontinuation of heparin. N Engl J Med 1992; 327: 141-145
12. Lindahl B, Venge P, Wallentin L. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group. Circulation 1996; 93: 1651-1657
13. Wallentin L, Husted S, Kontny F, Swahn E. Long-term low-molecular-weight heparin (Fragmin) and/or early revascularization during instability in coronary artery disease (the FRISC II Study). Am J Cardiol 1997; 80: 61E-63E
14. Gurfinkel E, Altman R, Scazziota A, Rouvier J, Mautner B. Importance of thrombosis and thrombolysis in silent ischaemia: comparison of patients with acute myocardial infarction and unstable angina. Br Heart J 1994; 71: 151-155
15. Badimon L, Badimon JJ. Mechanisms of arterial thrombosis in non-parallel streamlines: platelet thrombi grow on the apex of stenotic severely injured vessel wall. Experimental study in the pig model. J Clin Invest 1989; 84: 1134-1144
16. Hirsh PD, Hillis LD, Campbell WB, Firth BG, Willerson JT. Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease. N Engl J Med 1981; 304: 685-691
17. Maseri A, L'Abbate A, Baroldi G, Chierchia S, Marzilli M, Ballestra AM, et al. Coronary vasospasm as a possible cause of myocardial infarction. A conclusion derived from the study of "preinfarction" angina. N Engl J Med 1978; 299: 1271-1277
18. Dettori AG, Tagliaferri A, Dall'Aglio E, Pini M. Clinical pharmacology of a new low molecular weight heparin (Alpha LMWH-fluxum) : an update. Int Angiol 1988; 7 (Suppl 3): 7-18
19. Dettori AB, Babbini M. Human pharmacology of a new lowmolecular-weight heparin (Alpha LMWH-fluxum) : an update. Med Res Rev 1992; 12 : 373-389
20. Frampton JE, Faulds D. Parnaparin. A review of its pharmacology, and clinical application in the prevention and treatment of thromboembolic and other vascular disorders. Drugs 1994; 47: 652-676
21. Malhotra S, Bhargava VK, Grover A, Pandhi P, Sharma YP. A randomized trial to compare the efficacy, safety, cost and platelet aggregation effects of enoxaparin and unfractionated heparin (the ESCAPEU trial). Int J Clin Pharmacol Ther 2001; 39: 110-115
22. Klein W, Buchwald A, Hillis WS, Monrad S, Sanz G, Turpie AG, et al. Fragmin in unstable angina pectoris or in non-Q-wave acute myocardial infarction (the FRIC study). Fragmin in Unstable Coronary Artery Disease. Am J Cardiol 1997; 80: 30E-34E
23. Fox KA, Antman EM, Cohen M, Bigonzi F. For the ESSENCE/TIMI 11B Investigators. Comparison of enoxaparin versus unfractionated heparin in patients with unstable angina pectoris/non ST-segment elevation acute myocardial infarction having subsequent percutaneous coronary intervention. Am J Cardiol 2002; 90: 477-482
24. Antman EM, Cohen M, Radley D, McCabe C, Rush J, Premmereur J, et al. Assessment of the treatment effect of enoxaparin for unstable angina/non Q-wave myocardial infarction. TIMI 11B-ESSENCE meta-analysis. Circulation 1999; 100: 1602-1608
25. Husted S, Kher A. Acute and prolonged treatment with lowmolecular-weight heparin therapy in patients with unstable coronary artery disease. Ann Med 2000; 32 (Suppl 1): 53-59